Corporate GovernanceApr 30, 2026, 04:27 PM
ONMD Amends 10-K: Executive Comp, Ownership, Related Party & Delinquent Filings
AI Summary
OneMedNet Corp (ONMD) filed an Amendment No. 1 to its Form 10-K, providing previously omitted information regarding corporate governance, executive compensation, security ownership, and related party transactions. The amendment detailed 2025 compensation for named executive officers, including CEO Aaron Green ($1.11M), CFO Robert Golden ($0.50M), and CMO Dr. Jeffrey Yu ($0.54M). It also disclosed significant beneficial ownership by Dr. Thomas Kosasa (30.4%) and Dr. Jeffrey Yu (15.2%), along with related party investments and conversions of notes. Notably, the filing identified several delinquent Section 16(a) reports for directors and executive officers during 2025.
Key Highlights
- Multiple directors and executive officers had delinquent Section 16(a) reports in 2025.
- CEO Aaron Green's 2025 total compensation was $1,107,622, including $757,622 in stock awards.
- CFO Robert Golden's 2025 total compensation was $498,672, including $329,672 in stock awards.
- CMO Dr. Jeffrey Yu's 2025 total compensation was $537,848, including $237,848 in stock awards.
- Dr. Thomas Kosasa is the largest beneficial owner with 30.4% of common stock (16,693,243 shares).
- Dr. Jeffrey Yu beneficially owns 15.2% of common stock (8,343,710 shares).
- Related parties converted $1.66M in PIPE Notes into 1,453,174 shares at $1.14/share in June 2025.
- Related parties provided $12.3M in Convertible Promissory Notes from 2019-2023.
Price Impact
More from ONMD